Payment overview · 2025
General Payments
$19.25
1 reported records · 1 companies
Healthcare provider profile · identity verified
Robert Fernandez, MD
Allopathic & Osteopathic Physicians|Family Medicine · HUNTSVILLE, TX · NPI 1710985536
Verified facts
What the public records show
CMS Open Payments records show Robert Fernandez, MD received $19.25 in general payments during 2025 across 1 reported records.
Antares Pharma, Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Antares Pharma, Inc. | Unresolved — no canonical attribution shown | $19.25 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $19.25 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| XYOSTED Normalized: xyosted |
Drug | Antares Pharma, Inc. | $19.25 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 912 | 271 |
| Amlodipine Besylate | Amlodipine Besylate | 725 | 217 |
| Levothyroxine Sodium | Levothyroxine Sodium | 542 | 153 |
| Metoprolol Succinate | Metoprolol Succinate | 367 | 106 |
| Lisinopril | Lisinopril | 354 | 106 |
| Losartan Potassium | Losartan Potassium | 349 | 109 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 349 | 109 |
| Hydrochlorothiazide | Hydrochlorothiazide | 311 | 97 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 311 | 94 |
| Trazodone Hcl | Trazodone Hcl | 300 | 97 |
| Metformin Hcl | Metformin Hcl | 297 | 88 |
| Montelukast Sodium | Montelukast Sodium | 276 | 104 |
| Tamsulosin Hcl | Tamsulosin Hcl | 259 | 79 |
| Gabapentin | Gabapentin | 247 | 89 |
| Celecoxib | Celecoxib | 240 | 90 |
| Omeprazole | Omeprazole | 231 | 71 |
| Furosemide | Furosemide | 211 | 68 |
| Potassium Chloride | Potassium Chloride | 199 | 56 |
| Pravastatin Sodium | Pravastatin Sodium | 196 | 53 |
| Pantoprazole Sodium | Pantoprazole Sodium | 178 | 56 |
| Duloxetine Hcl | Duloxetine Hcl | 177 | 63 |
| Finasteride | Finasteride | 176 | 53 |
| Simvastatin | Simvastatin | 164 | 46 |
| Allopurinol | Allopurinol | 163 | 43 |
| Ramipril | Ramipril | 148 | 48 |
| Clopidogrel | Clopidogrel Bisulfate | 140 | 39 |
| Citalopram Hbr | Citalopram Hydrobromide | 139 | 39 |
| Ezetimibe | Ezetimibe | 139 | 47 |
| Famotidine | Famotidine | 137 | 55 |
| Fluticasone Propionate | Fluticasone Propionate | 136 | 55 |
| Valsartan | Valsartan | 135 | 41 |
| Alendronate Sodium | Alendronate Sodium | 126 | 28 |
| Meloxicam | Meloxicam | 124 | 43 |
| Sertraline Hcl | Sertraline Hcl | 123 | 34 |
| Mounjaro | Tirzepatide | 121 | 22 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 120 | 49 |
| Eliquis | Apixaban | 119 | 31 |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 119 | 41 |
| Escitalopram Oxalate | Escitalopram Oxalate | 118 | 33 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 113 | 37 |
| Glipizide Er | Glipizide | 112 | 38 |
| Metformin Hcl Er | Metformin Hcl | 111 | 39 |
| Carvedilol | Carvedilol | 104 | 37 |
| Metoprolol Tartrate | Metoprolol Tartrate | 104 | 25 |
| Buspirone Hcl | Buspirone Hcl | 91 | 31 |
| Topiramate | Topiramate | 91 | 38 |
| Hydralazine Hcl | Hydralazine Hcl | 86 | 27 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 81 | 28 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 79 | 23 |
| Nifedipine Er | Nifedipine | 78 | 23 |
| Pioglitazone Hcl | Pioglitazone Hcl | 77 | 25 |
| Spironolactone | Spironolactone | 77 | 24 |
| Jardiance | Empagliflozin | 76 | 28 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 72 | 24 |
| Bupropion Xl | Bupropion Hcl | 71 | 32 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 67 | 19 |
| Synthroid | Levothyroxine Sodium | 67 | 20 |
| Ozempic | Semaglutide | 66 | 12 |
| Tizanidine Hcl | Tizanidine Hcl | 65 | 29 |
| Januvia | Sitagliptin Phosphate | 59 | 17 |
| Prednisone | Prednisone | 57 | 44 |
| Atenolol | Atenolol | 54 | 13 |
| Azelastine Hcl | Azelastine Hcl | 54 | 25 |
| Benazepril Hcl | Benazepril Hcl | 49 | 13 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 47 | 12 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 47 | 14 |
| Ropinirole Hcl | Ropinirole Hcl | 44 | 12 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 42 | 27 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 41 | suppressed |
| Glimepiride | Glimepiride | 40 | 12 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 40 | 12 |
| Verapamil Er | Verapamil Hcl | 40 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 39 | 13 |
| Irbesartan | Irbesartan | 39 | suppressed |
| Spironolactone-Hctz | Spironolact/Hydrochlorothiazid | 38 | 14 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 37 | suppressed |
| Estradiol | Estradiol | 36 | 13 |
| Mirtazapine | Mirtazapine | 36 | 14 |
| Raloxifene Hcl | Raloxifene Hcl | 35 | 11 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 33 | suppressed |
| Trulicity | Dulaglutide | 33 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 32 | 12 |
| Fluoxetine Hcl | Fluoxetine Hcl | 32 | 11 |
| Paroxetine Hcl | Paroxetine Hcl | 31 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 31 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 30 | suppressed |
| Vascepa | Icosapent Ethyl | 30 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 29 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 29 | 12 |
| Xarelto | Rivaroxaban | 29 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 28 | suppressed |
| Lovastatin | Lovastatin | 28 | suppressed |
| Clonidine | Clonidine | 27 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 27 | 16 |
| Breo Ellipta | Fluticasone/Vilanterol | 26 | suppressed |
| Tradjenta | Linagliptin | 26 | suppressed |
| Icosapent Ethyl | Icosapent Ethyl | 25 | 13 |
| Ipratropium Bromide | Ipratropium Bromide | 25 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 24 | 22 |
| Fenofibrate | Fenofibrate | 24 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 24 | 11 |
| Nystatin | Nystatin | 24 | 15 |
| Diclofenac Sodium | Diclofenac Sodium | 23 | 14 |
| Glipizide | Glipizide | 23 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 23 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 21 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 21 | suppressed |
| Humalog Mix 75-25 Kwikpen | Insulin Lispro Protamin/Lispro | 21 | suppressed |
| Myrbetriq | Mirabegron | 21 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 21 | 18 |
| Testosterone Cypionate | Testosterone Cypionate | 20 | suppressed |
| Klor-Con 10 | Potassium Chloride | 19 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 19 | suppressed |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 18 | suppressed |
| Primidone | Primidone | 18 | suppressed |
| Colesevelam Hcl | Colesevelam Hcl | 17 | suppressed |
| Minoxidil | Minoxidil | 17 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 17 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 17 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 16 | suppressed |
| Mupirocin | Mupirocin | 16 | 12 |
| Breyna | Budesonide/Formoterol Fumarate | 15 | suppressed |
| Cilostazol | Cilostazol | 15 | suppressed |
| Memantine Hcl | Memantine Hcl | 15 | suppressed |
| Rabeprazole Sodium | Rabeprazole Sodium | 15 | suppressed |
| Testosterone | Testosterone | 15 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 14 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 14 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 14 | suppressed |
| Glyburide | Glyburide | 14 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 14 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 14 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 14 | suppressed |
| Vilazodone Hcl | Vilazodone Hcl | 14 | suppressed |
| Acyclovir | Acyclovir | 13 | suppressed |
| Azithromycin | Azithromycin | 13 | 12 |
| Clotrimazole | Clotrimazole | 13 | suppressed |
| Fenofibric Acid | Fenofibric Acid (Choline) | 13 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 13 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 13 | 12 |
| Baclofen | Baclofen | 12 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 12 | suppressed |
| Klor-Con M20 | Potassium Chloride | 11 | suppressed |
| Levemir | Insulin Detemir | 11 | suppressed |
| Mirabegron Er | Mirabegron | 11 | suppressed |
| Novolog Flexpen | Insulin Aspart | 11 | suppressed |
| Soliqua 100-33 | Insulin Glargine/Lixisenatide | 11 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 11 | suppressed |
| Telmisartan | Telmisartan | 11 | suppressed |
| Temazepam | Temazepam | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $19.25 · 1 records | Antares Pharma, Inc. | XYOSTED | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error